Monthly Archives - February 2020

Being an Underdog with Laurel Taylor

Underdog stories are everywhere — in film, TV, the news, and all manner of books. They are classic heroic tales about the ones no one bet on (and many bet against) coming out on top. Laurel Taylor is the Founder and CEO of She learned to embrace being underestimated and treated that rejection as a catalyst for something more. Read more >>

Advancing Platelet-Based Therapeutics for Patients

Platelet BioGenesis (PBG) reports that it is working with the Canadian Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare Life Sciences to develop customized media formulations that will enable efficient differentiation of stem cells to platelet-based treatments, thereby avoiding the reliance on blood donors in the future. Read more >>

Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it plans to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Corbus. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms […]